Listen to Eli Lilly’s Orforglipron Injectables vs. Oral Tablets Which Actually Works?

Just when we got used to the weekly jab, there is a brand-new weight loss player entering the game—and this time, it’s a daily tablet. Eli Lilly is working on a fresh molecule called Orforglipron, but if you think it is just a copy-and-paste job of Mounjaro in a pill format, think again. There is a fascinating world of difference in how our bodies process oral medications compared to standard injectables.

From the strict daily routine required to keep your dosage steady, to the downright shocking ways everyday essentials like a morning cup of tea or a slice of grapefruit can completely destroy your body’s ability to absorb medication, we are breaking down the honest facts. It is all about figuring out what your individual health journey actually needs, rather than just chasing the latest convenience. ⚠️ Nothing discussed in this episode constitutes medical advice. If you are experiencing symptoms described in this conversation, seek medical attention immediately and consult a qualified healthcare professional.

KEY TAKEAWAYS

A Different Scientific Approach: Orforglipron is a small-molecule drug that targets the GLP-1 receptor, meaning it survives stomach digestion unlike protein-based peptide injectables.

Better Results Than Previous Pills: Trials show the drug yields around 9-10% body weight loss over six months, outperforming older oral options like Rybelsus.

The Absorption Trap: Oral tablets are highly sensitive to food and drink; consuming items like tea or grapefruit can actively block your body from absorbing the medicine.

The Cost Misconception: While manufacturing a pill is typically less expensive than an injection, market pricing is highly likely to remain the same.

Identical Side Effect Profiles: Changing the format to a tablet does not reduce risk; one in ten trial patients still had to stop the drug due to severe nausea and vomiting.

QUOTES

“If you take a protein by mouth, guess what your stomach and your digestion does to it, it digests it so it doesn’t work.”

“We mustn’t confuse these as the only treatments that people should consider for weight loss.”

“The injectable gets right into the system, and it’s steady.”

“The cost of production does not reflect the price. The price is what the market will pay.” “Just because it’s a tablet doesn’t mean it’s any safer.”

Follow & Connect with KIO Method

Website: ⁠⁠https://www.kiomethod.com⁠

⁠⁠⁠ YouTube: ⁠⁠https://www.youtube.com/@kiomethod⁠

⁠⁠⁠ Instagram: ⁠⁠https://www.instagram.com/kiomethod⁠

⁠⁠⁠ TikTok: ⁠⁠https://www.tiktok.com/@kiomethod⁠

⁠⁠⁠ Facebook: ⁠⁠https://www.facebook.com/kiomethod⁠

⁠⁠⁠ LinkedIn: ⁠⁠https://www.linkedin.com/company/kiomethod⁠⁠

Dr Shaw Somers Information https://www.instagram.com/mrshawsomers/

https://www.shawsomers.com/ ⁠

HOST BIO

Mel Harris is a weight loss mentor, podcast host, and founder of KIO Method Ltd, specialising in long-term weight loss maintenance after bariatric surgery and weight loss injections. After losing nearly 15 stone (90kg) following weight loss surgery in 2004, Mel has spent over 20 years navigating the realities of keeping weight off.

With lived experience of bariatric surgery, weight regain, GLP-1 medications, and metabolic health challenges, Mel is on a mission to close the gap between losing weight and keeping it off for life. Through honest, compassionate conversations, she cuts through misinformation, diet culture, and shame — offering real support, insight, and zero judgement.